| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/17/1996 | EP0691845A1 Use of cis- or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 01/17/1996 | EP0691843A1 RETARDED-ACTION MICROTABLET MADE OF -g(b)-PHENYLPROPIOPHENONE DERIVATIVES |
| 01/17/1996 | EP0691842A1 Lidocaine aerosol anaesthetic |
| 01/17/1996 | EP0691811A1 Coated microparticle agglomerates |
| 01/17/1996 | EP0691810A1 Multiply-coated particles |
| 01/17/1996 | EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use. |
| 01/17/1996 | EP0634925B1 Supersaturated topical compositions |
| 01/17/1996 | EP0597834B1 Delivery system comprising means for controlling internal pressure |
| 01/17/1996 | EP0522128B1 Water-dispersible tablets |
| 01/17/1996 | EP0471036B1 Encapsulation process |
| 01/17/1996 | CN1114903A A styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
| 01/17/1996 | CN1114891A "Yinhuang" inhalation, spray agent (snuff bottle), enema liquid and its preparation method |
| 01/17/1996 | CN1114887A Preparation method of traditional Chinese medicine preparation "Zhikuining" |
| 01/17/1996 | CN1114885A External-use medicine powder for health care, nourishing kidney and clearing brain |
| 01/17/1996 | CN1114879A Method of administering azithromycin |
| 01/17/1996 | CN1114876A Use of a spin trap in a cosmetic or dermatological composition |
| 01/17/1996 | CN1030687C Preparation method of urethra feed medicine agent |
| 01/16/1996 | US5484809 Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
| 01/16/1996 | US5484801 Pharmaceutical composition for inhibiting HIV protease |
| 01/16/1996 | US5484800 Lipid-based liquid medicinal composition |
| 01/16/1996 | US5484776 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration |
| 01/16/1996 | US5484610 pH and temperature sensitive terpolymers for oral drug delivery |
| 01/16/1996 | US5484609 Therapeutic compositions and methods |
| 01/16/1996 | US5484608 Sustained-release drug delivery system |
| 01/16/1996 | US5484607 Extended release clonidine formulation |
| 01/16/1996 | US5484606 Stability |
| 01/16/1996 | US5484605 Agent for treating chronically inflammatory intestinal diseases |
| 01/16/1996 | US5484604 Cross-linked alginate transdermal medicine delivery devices |
| 01/16/1996 | US5484603 Percutaneous anaesthesia |
| 01/16/1996 | US5484602 Drug contained in lollipop |
| 01/16/1996 | US5484584 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 01/16/1996 | CA1337928C Topically applied gold organic complex |
| 01/14/1996 | CA2153553A1 Stable lipid emulsion |
| 01/11/1996 | WO1996000790A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | WO1996000610A1 Method and apparatus for the formation of particles |
| 01/11/1996 | WO1996000576A2 Novel clinical uses of polyene macrolides |
| 01/11/1996 | WO1996000567A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 01/11/1996 | WO1996000566A1 A mouldable alum composition |
| 01/11/1996 | WO1996000564A1 Four-component aerosol composition |
| 01/11/1996 | WO1996000543A1 A device and method for acidic buffering |
| 01/11/1996 | WO1996000537A1 Microcapsules for administration of neuroactive agents |
| 01/11/1996 | WO1996000506A1 Stabilized composition comprising colistin sulfate |
| 01/11/1996 | WO1995031955A3 Formulation preparation device |
| 01/11/1996 | DE4446380A1 Hydrogel für die Applikation von therapeutischen und/oder kosmetischen Wirkstoffen an die Haut Hydrogel for the application of therapeutic and / or cosmetic agents to the skin |
| 01/11/1996 | DE4423850A1 Transdermal delivery device for naloxone hydrochloride |
| 01/11/1996 | CA2194049A1 Novel clinical uses of polyene macrolides |
| 01/11/1996 | CA2190883A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/10/1996 | EP0691407A1 Non-reducing saccharide and its production and use |
| 01/10/1996 | EP0691344A1 Purification of trehalose |
| 01/10/1996 | EP0691121A2 Method and apparatus for manufacturing tablets |
| 01/10/1996 | EP0691079A2 Enteral composition for diabetic patients |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690912A1 Recombinant avian adenovirus vector |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690747A1 Extrusion and freeze-drying method for preparing particles containing an active ingredient |
| 01/10/1996 | EP0690735A1 A plaster working as a dosing device |
| 01/10/1996 | EP0690728A1 Preservative system for contact lens solutions |
| 01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
| 01/10/1996 | EP0690708A1 Cosmetic composition |
| 01/10/1996 | EP0690671A1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 01/10/1996 | EP0656026A4 Polyarylates containing derivatives of the natural amino acid l-tyrosine. |
| 01/10/1996 | EP0630236B1 Self-assembling diketopiperazine drug delivery system |
| 01/10/1996 | EP0610441A4 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release. |
| 01/10/1996 | EP0609321B1 Stabilized calorific nutrient solution and multi-chamber system for the parenteral feeding of humans |
| 01/10/1996 | EP0605578B1 Pressurised aerosol compositions |
| 01/10/1996 | EP0599850B1 Composition and method for treating cystic fibrosis |
| 01/10/1996 | EP0527946B1 Controlled release vehicle |
| 01/10/1996 | EP0471084B1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
| 01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
| 01/10/1996 | CN2216832Y Laminated compound medicinal adhesive plaster |
| 01/10/1996 | CN1114824A 1 alpha, 24-(OH)2-vitamin D3 emulsion composition |
| 01/10/1996 | CN1114588A Formulations for orally administered pharmaceutical agents |
| 01/10/1996 | CN1114587A EVA-based transdermal matrix system for the administration of an oestrogen and/or progestogen |
| 01/10/1996 | CN1114584A Medicine for tonifying brain and raising intelligence |
| 01/10/1996 | CN1114583A Colour-restoring ointment for treating burn or scald |
| 01/10/1996 | CN1114575A Fangbing Jianshenbao-a health-care product capable of preventing disease |
| 01/10/1996 | CN1114566A Spray for preventing AIDS and VD and preparation method thereof |
| 01/10/1996 | CN1114562A Medicinal cream type and foam type endogastric flotation slow-releasing agent and preparing method thereof |
| 01/10/1996 | CN1114561A Oral gelatinous semi-solid medicament dosage form and its package |
| 01/10/1996 | CN1114560A Fibre agglomerate containing medicine particles with preset falling speed and preparing method thereof |
| 01/10/1996 | CN1114559A Composition and application against senile plaque formed on skin and/or slow death |
| 01/10/1996 | CN1114558A Depigmenting composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof |
| 01/09/1996 | US5482988 Hot-melt silicone pressure sensitive adhesive with siloxylated polyether waxes as additives |
| 01/09/1996 | US5482973 Suppository preparation |
| 01/09/1996 | US5482970 Transdermal antiandrogenic compositions and modulated process |
| 01/09/1996 | US5482965 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers for physiological active agents |
| 01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
| 01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 01/09/1996 | US5482931 Stabilized pharmaceutical peptide compositions |
| 01/09/1996 | US5482929 Aluminum salt of cyclodextrin sulfate |
| 01/09/1996 | US5482927 Injectable particles with active protein |
| 01/09/1996 | US5482719 Drug delivery systems |
| 01/09/1996 | US5482718 Tablet with cellulose ether erodible coating overcoated with enteric coating |
| 01/09/1996 | US5482707 Drinking slurry through coated straw; taste |
| 01/09/1996 | US5482706 A physiologically active peptide or protein and a cytidine nucleotide |
| 01/09/1996 | US5482053 Condom lubricants containing zinc as an anti-viral agent |
| 01/09/1996 | US5482039 Process for diagnosing erectile dysfunction, and related methods of treatment |
| 01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
| 01/09/1996 | CA2044151C Hydrophilic polymer-silicate mineral complex material and use thereof |